| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The delisting of ADRs is the next step in the company's long-term strategy
SÃO PAULO, 18 January 2024 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that its Board of Directors has approved a plan to end the company's secondary listing of American Depositary Shares (ADSs) on the New York Stock Exchange (NYSE), while maintaining its primary listing of common shares on the B3 stock exchange in São Paulo.
In line with the company's long-term strategic objectives of simplifying operations, Natura &Co has decided to discontinue its secondary listing on the NYSE, as the vast majority of Natura &Co trading activity is concentrated on the B3 stock exchange. The decreasing trading volume of Natura &Co ADRs on the NYSE no longer makes maintaining the listing a compelling option.
The delisting is expected to be effective 10 days after the filing with the U.S. Securities and Exchange Commission (the "SEC") of a Form 25. Natura &Co expects the NYSE to suspend trading in the ADSs on or about 9 February 2024.
Natura &Co has not arranged for listing, quotation and/or registration of the ADRs on another securities exchange or quotation medium.
Fabio Barbosa, Chief Executive Officer of Natura &Co, stated: "The planned delisting of Natura &Co from the New York Stock Exchange is consistent with our long-term strategy for the business. This move underscores our continued focus on simplifying our operations to reduce complexity. We thank Natura &Co investors who held ADRs and look forward to welcoming many of them as shareholders on the B3 market. Upholding our dedication to transparency, we will maintain our high disclosure standards through our listing in Brazil."
Posted In: NTCO
